TANG CAPITAL MANAGEMENT LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001232621

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth Tilt how tags are computed

Q4 2024 · 183 positions · Total reported value $1.51B · Top-10 concentration 37.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 15.2% · 5 new · 1 cut · 1 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.5% · vs SPY -10.6% · Prev Value $2.20B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.0% · vs SPY -5.2% · Latest Value $2.17B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, TANG CAPITAL MANAGEMENT LLC disclosed 183 equity positions with a combined reported value of $1.51B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 37.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt.

The largest disclosed positions as of Q4 2024 were TARS ($124.85M), AUPH ($75.70M), LKFT ($59.43M). By sector, the heaviest allocations are Health Care 78.0%, Technology 2.7%. Versus the prior quarter, allocation shifted toward Health Care (+1.8pp), Consumer Discretionary (+0.8pp) and away from Other (-3.0pp).

Versus the prior quarter, TANG CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 1 and fully exited 1, a turnover rate of 15.2% of positions. The portfolio's overlap with the prior quarter was 73% of names.

The largest new positions opened in Q4 2024 were LEGN ($14.64M), MRNA ($12.47M), ADMA ($9.43M).

Of the 1 positions fully exited versus the prior quarter, the largest were RVNC ($12.97M), IMNM ($10.53M), CNTA ($6.40M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • LEGN LEGEND BIOTECH CORP · $14.64M
  • MRNA MODERNA INC · $12.47M
  • ADMA ADMA BIOLOGICS INC · $9.43M
  • EWTX EDGEWISE THERAPEUTICS INC · $8.01M
  • EPIX ESSA PHARMA INC · $7.70M
  • BIOA BIOAGE LABS INC · $7.63M
  • IBRX IMMUNITYBIO INC · $7.20M
  • DERM JOURNEY MED CORP · $6.75M

Fully Exited (vs previous quarter)

  • RVNC REVANCE THERAPEUTICS INC · prev qtr: $12.97M
  • IMNM IMMUNOME INC · prev qtr: $10.53M
  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $6.40M
  • GPCR STRUCTURE THERAPEUTICS INC · prev qtr: $6.34M
  • RPHM RENEO PHARMACEUTICALS INC · prev qtr: $5.01M
  • ARVN ARVINAS INC · prev qtr: $4.43M
  • TYRA TYRA BIOSCIENCES INC · prev qtr: $3.53M
  • PCRX PACIRA BIOSCIENCES INC · prev qtr: $921.45K

Insider Transactions (Form 4)

Latest TANG CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-10 Buy Boundless Bio, Inc. 249 $2.40 SEC filing
2026-11-06 Buy Boundless Bio, Inc. 1,700 $2.40 SEC filing
2026-11-05 Buy Boundless Bio, Inc. 8,390 $2.40 SEC filing
2026-11-04 Buy Boundless Bio, Inc. 517 $2.40 SEC filing
2026-11-03 Buy Boundless Bio, Inc. 2,255 $2.40 SEC filing
2026-10-27 Buy Boundless Bio, Inc. 10,707 $2.40 SEC filing
2026-10-26 Buy Boundless Bio, Inc. 9,606 $2.38 SEC filing
2026-10-23 Buy Boundless Bio, Inc. 6,234 $2.38 SEC filing

All insider transactions →

Fund Profile

Tang Capital Management is an SEC-registered 13F filer. As of Q3 2026 it reported 45 US equity positions with a combined value of $2.17B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 45 positions · $2.17B reported value (Q3 2026)
  • Top 10 holdings = 64.3% of reported value
  • Largest position: AUPH (AURINIA PHARMACEUTICALS INC) at 9.7%
  • Average position size: $48.31M

Sector Tilt

  • Health Care 89.7%
  • Information Technology 1.5%
  • (classified holdings cover 91% of value)

Quarterly Activity

  • Q3 2026: 5 new, 12 added, 1 reduced, 1 exited
  • 27 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 78.0%
Technology 2.7%
Financials 0.2%
Other 16.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.25M $124.85M 8.26%
8.26%
Hold
2 8.43M $75.70M 5.01%
5.01%
Add
3 2.16M $59.43M 3.93%
3.93%
Add
4 5.00M $55.17M 3.65%
3.65%
Add
5 1.24M $51.15M 3.38%
3.38%
Reduce
6 2.49M $47.79M 3.16%
3.16%
Add
7 1.56M $45.89M 3.04%
3.04%
Add
8 4.89M $41.45M 2.74%
2.74%
Add
9 8.07M $33.24M 2.20%
2.20%
Add
10 2.70M $32.70M 2.16%
2.16%
Add
11 700.00K $31.60M 2.09%
2.09%
Hold
12 270.00K $30.77M 2.04%
2.04%
Hold
13 1.50M $27.52M 1.82%
1.82%
Hold
14 300.00K $25.06M 1.66%
1.66%
Hold
15 300.00K $24.56M 1.62%
1.62%
Hold
16 1.85M $23.62M 1.56%
1.56%
Reduce
17 766.94K $22.14M 1.47%
1.47%
Hold
18 150.00K $20.48M 1.35%
1.35%
Hold
19 2.75M $19.83M 1.31%
1.31%
Hold
20 142.57K $19.15M 1.27%
1.27%
Reduce
21 1.33M $17.62M 1.17%
1.17%
Hold
22 317.50K $17.55M 1.16%
1.16%
Reduce
23 140.00K $17.24M 1.14%
1.14%
Hold
24 1.10M $16.10M 1.07%
1.07%
Hold
25 4.79M $16.04M 1.06%
1.06%
Add
26 1.50M $15.74M 1.04%
1.04%
Add
27 26.60K $15.57M 1.03%
1.03%
Add
28 450.00K $14.64M 0.97%
0.97%
New
29 400.00K $13.53M 0.90%
0.90%
Reduce
30 270.00K $13.02M 0.86%
0.86%
Add
31 1.10M $12.94M 0.86%
0.86%
Add
32 320.00K $12.88M 0.85%
0.85%
Add
33 1.40M $12.73M 0.84%
0.84%
Hold
34 300.00K $12.47M 0.82%
0.82%
New
35 628.61K $12.43M 0.82%
0.82%
Hold
36 1.33M $11.73M 0.78%
0.78%
Add
37 2.35M $11.27M 0.75%
0.75%
Hold
38 921.14K $11.22M 0.74%
0.74%
Hold
39 266.50K $10.49M 0.69%
0.69%
Hold
40 3.90M $10.37M 0.69%
0.69%
Hold
41 4.92M $10.18M 0.67%
0.67%
Hold
42 150.00K $9.83M 0.65%
0.65%
Hold
43 800.00K $9.69M 0.64%
0.64%
Add
44 281.20K $9.68M 0.64%
0.64%
Hold
45 550.00K $9.43M 0.62%
0.62%
New
46 750.00K $9.43M 0.62%
0.62%
Hold
47 640.00K $9.23M 0.61%
0.61%
Reduce
48 1.48M $9.14M 0.60%
0.60%
Hold
49 5.90M $8.55M 0.57%
0.57%
Add
50 450.00K $8.13M 0.54%
0.54%
Add

FAQ

What did TANG CAPITAL MANAGEMENT LLC buy in 2024-Q4?

In its 2024-Q4 13F filing, TANG CAPITAL MANAGEMENT LLC reported 183 equity positions worth $1.51B in aggregate; its largest disclosed positions were TARS ($124.85M), AUPH ($75.70M), LKFT ($59.43M).

How large is TANG CAPITAL MANAGEMENT LLC's portfolio?

TANG CAPITAL MANAGEMENT LLC reported $1.51B of long equity holdings across 183 positions as of 2024-Q4. Top-10 holdings account for 37.5% of reported value.

What is TANG CAPITAL MANAGEMENT LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tang-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →